Membrane-bound pyrophosphatases are homodimeric integral membrane proteins that hydrolyse pyrophosphate into orthophosphates, coupled to the active transport of protons or sodium ions across membranes. They are important in the life cycle of bacteria, archaea, plants, and protist parasites, but no homologous proteins exist in vertebrates, making them a promising drug target.
Introduction
Membrane-bound pyrophosphatases (mPPases) are a family of enzymes that hydrolyse pyrophosphate into two phosphates and couple this with proton and/or sodium transport across the membrane, thus creating an electrochemical gradient. These enzymes were initially discovered in photosynthetic bacteria and plants 1,2,3 . They were later found in protist parasites, archaea, and certain species of bacteria, but do not occur in animals and humans 4, 5 . In various organisms, these proteins are important for the survival under diverse stress situations due to energy limitation, such as osmotic stress, anoxia, mineral deficiency, low temperature, and intense light 6 . In bacteria and archaea, mPPases reside in the cell membrane 4 , while in protists, algae and plants, the proteins can also be located in acidocalcisomes, the vacuole, and/or Golgi apparatus 7, 8 .
mPPases are homodimeric. Each monomer contains 15-17 transmembrane helices with a molecular weight of 70-81 kDa. So far, there are structures of only two mPPases: four from Thermotoga maritima (TmPPase) and two for mung bean (Vigna radiata: VrPPase). TmPPase structure has been solved in the resting state (TmPPase:Ca:Mg) 9 , with two phosphates bound (TmPPase:2P i ) 9 , with the substrate-analogue imidodiphosphate (IDP) bound (TmPPase:IDP) 10 , and with the phosphate analogue (WO 4 )-bound (TmPPase: WO 4 ) 10 . VrPPase has been solved in the IDP-bound (VrPPase:IDP) 11 and single phosphate-bound states (VrPPase:P i ) 10 . In all the structures, the mPPase is a symmetric homodimer with each monomer consisting of 16 transmembrane helices (TMHs).
These helices form two concentric layers with six helices (TMH5-6, 11-12, and 15-16) forming the inner layer and the other ten (TMH 1-4, 7-10, and [13] [14] forming the outer layer. Each monomer consists of four regions: a hydrolytic centre, a coupling funnel, an ion gate, and an exit channel 12 ( Fig. 1a) . The hydrolytic centre and coupling funnel are comprised of TMH5-6, 11-12, and 15-16 (Fig. 1b) . Upon binding of substrate, the active site is closed by a long loop between TMH5 and TMH6 and opened again after hydrolysis and ion pumping 9, 10, 11 . In the structure of TmPPase:IDP, the Na + binds within the membrane plane at the ionic gate between TMH6 and TMH16. Na + is pentacoordinated by the carboxylate groups of D243 6.50 , E246 6.53 , and D703 16.46 , the O of S247 6.54 and with the main-chain carbonyl of D243 6.50 10 15, 16, 17 .
The mPPases, along with a V-ATPase, maintain the ionic gradient across the acidocalcisome membrane, which is necessary for acidocalcisome function, such as osmotic homeostasis upon passage of the parasite from the insect vector into the mammalian bloodstream 8 . Indeed, knockdown/knockout of mPPases causes severe reduction in polyphosphate and the loss of acidocalcisome acidity, leading to the failure of the parasites to stabilize their intracellular pH upon exposure to external basic pH 18 . In addition, it has been shown that mPPase is essential for virulence of T. gondii in a mouse model 19 , and both mPPases are essential genes in P. falciparum (Totanes, unpubl.) . mPPases are thus promising targets for structure-based drug design because they are essential, do not exist in multicellular animals, and structures in different conformations are known.
Non-hydrolysable PP i analogues are not viable mPPase drug candidates, as they will inhibit the many human enzymes that produce or hydrolyse PP i , from inorganic pyrophosphatases to polymerases and ectonucleotide pyrophosphatase/phosphodiesterases 20 . Our goal is thus the discovery of drug-like small molecular weight compounds that would specifically inhibit mPPases from protist parasites 13 . Here, we report the first non-phosphorous non-substrate analogue low
carboxamide (ATC), its preliminary structure-activity relationships, and a 3.7 Å resolution structure of ATC bound to TmPPase. The binding site of ATC is allosteric and furthermore asymmetric with respect to the structural homodimer, providing strong evidence that the substrate binding and catalysis events process asymmetrically.
Results

Structure overview
We solved the 3.7 Å resolution of TmPPase structure in complex with IDP and ATC (TmPPase:IDP:ATC) by molecular replacement using the TmPPase:IDP structure (PDB ID: 5LZQ) 10 as the search model but with the IDP removed. Molecular replacement identified four
TmPPase molecules (two dimers) in the asymmetric unit. After the first round of refinement, we observed positive F o -F c density at 3.0 σ at the hydrolytic centre ( Supplementary Fig. 1a ) and at the ionic gate ( Supplementary Fig. 1b ) in all four monomers. We built the Mg 5 IDP complex into the former and a sodium ion into the latter. We also observed positive 3.0 σ F o -F c density near the exit channels of chains A and C that could be fit with ATC molecules. Two molecules of ATC (ATC-1 and ATC-2) could be fit at the interface between A and D ( Fig. 2a and Supplementary Fig. 1c ), but only one (ATC-3) between B and C, as the density there was weaker (data not shown). After refinement, manual rebuilding and manual placement of the IDP and ATC into the electron density, we were able to refine it to an R work /R free of 22.5%/26.8% with acceptable stereochemistry (Table   1) . Unlike previously solved TmPPase structures 9, 10 , there are four molecules (two dimers, AB and CD) in the asymmetric unit ( Supplementary Fig. 2a ). The root mean squared deviation (RMSD) per Cα is 0.30 Å 2 for the AB versus CD dimer, and 0.245-0.304 Å 2 when comparing individual monomers (Supplementary Table 1 ).
There are thus two dimer interfaces in the crystal structure: the AB dimer described before 9,10 and ATC-mediated AD and BC dimers ( Supplementary Fig. 2 ). Are these latter dimers physiologically relevant? It is fairly clear that the answer is no. First, the interactions are weak for a protein interface (219 Å 2 buried) and the proteins interact tail to tail ( Supplementary Fig. 2b ), placing the extracellular loops together in a manner that would not allow a bilayer to form. Second, sizeexclusion chromatography-multiangle laser light scattering (SEC-MALLS) analysis showed that the addition of ATC to the TmPPase:IDP complex (158.9 ± 0.1 kDa) did not change the oligomerisation state of the protein (162.8 ± 3.7 kDa for TmPPase:IDP:ATC complex) ( Supplementary Fig. 3 ). ATC clearly interacts as a dimer, binding to both the E 2 S and E 2 S 2 complexes in solution (Table 4) . We have shown this both structurally and functionally, as we describe below.
The overall structure of TmPPase:IDP:ATC complex is very similar to the structure of the (Fig. 1c) . This is in contrast to TmPPase:IDP, where Na + appears to be pentacoordinated, with the fifth ligand being the main-chain carbonyl oxygen of D243 6.50 . The C=O-Na + distance is 2.8 Å, versus 3.6 Å in the TmPPase:IDP:ATC structure. This is mostly because the sodium ion appears to be translated by about ~1.2 Å (see Methods). We believe that these changes are structurally and functionally significant and related to the binding of ATC (see Asymmetry below).
ATC binds in a cleft beside the exit channel
During refinement, we observed extra density near chains A and D ( Supplementary Fig. 1c ), into which we were able to model ATC. ATC is a rigid multiring system with only two free torsion angles, which we modeled in trans geometry, the most prevalent in solution (Supplementary Info.
NMR spectra). We could thus, even at this low resolution ( Supplementary Fig. 1c The cleft binds two ATC molecules stacked tail-to-tail through π-stacking interactions (Fig. 2) .
Strands β1-2 (loop6-7), loop8-9, and loop12-13 near the exit channel of chain A form a hydrophobic cleft with loops 2-3 and 4-5 on chain D (Fig. 3a) . Fig. 2b ). Chain A D351 (Oδ2) forms a salt bridge with the 2-aminothiazole on ATC-2 while chain A G528 (C=O) forms a bifurcated H-bond to the 2-aminothiazole on ATC-1 (N19 and N20; see Supplementary Fig. 1d for atom numbering of ATC) ( Table 2 , Fig. 2b ). In chain D, on the other hand, the chief interactions do not seem as strong: a single hydrogen bond is formed, the N157 Oδ1 hydrogen bonds N20 on ATC-2, and the remaining interaction are hydrophobic stacking of W164 on ATC-1, and the indole of ATC-2 sandwiched between W74 and W164 and stacking on Y161 ( Table 2 , Fig. 2c ). The interactions are likely due to crystal packing as the binding of ATC to the protein did not change the protein oligomerization in solution ( Supplementary Fig. 3 ). We therefore focus on the interactions of the ATC dimer with chain A.
Asymmetry
There is recent evidence of functional asymmetry in K + -dependent mPPases in the presence of excess potassium 22 . Here we show the first structural evidence of asymmetry. The IDP-bound state has the most symmetrical structure (the lowest rmsd values) between each monomer compared to others ( Table 3 , Supplementary Fig. 4a ). However, the binding of ATC makes the dimeric protein asymmetric, especially in the loops that interact with the inhibitor (loops8-9, β1−2 and 12-13). The maximum rmsd is 1.6 Å ( ATC binds as a dimer in chain A, holding the β1-2 loop (Q268, K269, I270, and Q277), loop8-9 (Q348, D351, and V352), and loop12-13 (G528, P530, and P531) together ( Table 2 ). This is due to the interactions with the ATC dimer ( Fig. 3b , Table 2 ). In contrast, the RMSDs/Cα for the other loops that interact with ATC are smaller (Table 3) . When all the TmPPase states are compared, it is clear that the β1-2 loop moves closer/away relative to loop12-13 and the dimer interface of the protein (Fig. 3c ). In particular, the binding of ATC causes the β1-2 strand of chain A to move away from the dimer interface relative to its position in TmPPase:IDP and TmPPase:P i2 to roughly the same angle as in the resting and P i structures (Fig. 3c , inset bottom view; periplasmic side) -when the exit channel must be closed. The movement of chain A β1-2 due to the binding of the ATC dimer thus create a hydrophobic clamp that locks the TmPPase exit channel in a closed state after substrate binding. In contrast, it is reasonable to assume that ATC does not bind to chain B because the β1-2 strand is moving away from the loop12-13, closer to its position in the resting state (Table 3 and Supplementary Fig. 5a ). This movement appears to prevent ATC binding because it leads to the protrusion of Q268 and Q277 that occlude the ATC binding site ( Supplementary Fig. 5b ).
Pharmacology of ATC and analogues at TmPPase
Together with ATC, we identified four of its analogues (compound 2, compound 3, compound 4, compound 5 ( Fig. 4a) . A set of four analogues (6, 7, 8, and 9), three of them brominated, were then designed for structural studies. Their IC 50 s were at least 20 times worse than the original hit ATC (Fig. 4b , c), and they did not help us solve the structure. They do, however, provide some insight into the structure-activity relationship (SAR) for this family of compounds on TmPPase.
The suggested binding modes also explain the structure-activity relationships (SARs) of the compounds presented in Figure 4 . First, they highlight that the hydrogen bonding functionality of the indole ring is important; compounds 2 and 3 that lack such a functionality are inactive. In the 
ATC binds tightly to the E 2 S form
As ATC is a potent inhibitor, we further characterized its effect on the rate of substrate (PP i )
hydrolysis using a range of compound concentrations (0.0 -4.0 μM). We performed the kinetic assay using PP i concentration of 0 -1714 μM at 71°C with 2 minutes of reaction time (Fig. 4d ).
The simultaneous analysis of the data for all inhibitor and substrate concentrations is consistent with a model in scheme 1 with equation (1) and n=2 (Table 4) , with the exception that K I1 is not fit (when we included it, the residuals did not improve, and its mean value is >0.5 mM; data not shown). The standard deviation of the residuals (Sy.x) for the dimer fit is 2.0 for scheme 1 where n=2, but 4.3 when n=1, and the curves clearly do not fit (data not shown). This means that ATC binds as a dimer to TmPPase. ATC clearly binds tightest to the E 2 S complex (K I2 = 1.8
and the binding to E 2 S 2 is 5-fold weaker (10.0 േ 1.1 µM) and no binding to E 2 (Table 4) . ATC is thus an uncompetitive dimeric inhibitor with a clear preference for binding to the single-substrate bound form. After the binding of substrate to monomer A (E 2 S), monomer B of TmPPase showed higher affinity to the substrate to form E 2 S 2 complex as the α value is very low (0.12). However, after both monomers bind substrate (E 2 S 2 ), the hydrolysis rate decreases by twenty-fold (β = 0.05) compared to the rate of hydrolysis of the E 2 S complex (k p = 239.2 േ 32.2 µmol P i /mg/min) ( Table   4 ).
Overall, it is clear that TmPPase shows positive cooperativity for substrate binding but negative cooperativity for hydrolysis, one where only the E 2 S form binds the ATC inhibitor tightly. In the crystal structure we solved, ATC is bound to the E 2 S 2 form, not to the E 2 S form. This is probably because the concentration of ATC added for crystallization was higher (1 mM) than the binding affinity of ATC to the E 2 S 2 form (10.0 µM) or because the ATC binding to E 2 S form can still induce the conformational change in the other monomer that allows further substrate binding (see Discussion) . This is consistent with the fact that we were unable to crystallise the TmPPase:ATC complex except in the presence of IDP as a competitive inhibitor. ATC is thus the first nonphosphorus and the first allosteric inhibitor identified for mPPase.
Use of ATC in designing inhibitors of parasitic mPPases
ATC would be a potential lead as an antiparasitic agent if it were active against protozoan parasites like Plasmodium spp. Preliminary studies with isolated P. falciparum membranes showed that ATC had an IC 50 around 80 μΜ (Vidilaseris, unpubl.), i.e at least 40-fold lower than in our test system T. maritima (Fig. 4a ). In the P. falciparum survival assays, ATC did not show any anti-plasmodial activity ( Supplementary Fig. 6 ). On the other hand, knockout of mPPases by RNAi in T. brucei 23 and in P. falciparum (Totanes, unpubl.) demonstrate that functional mPPase is required for survival and virulence.
To explain these findings and study the potential specificity determinants at the binding sites of ATC-1 and ATC-2 across mPPases, we retrieved the sequences of 16 mPPases from protozoan parasites ( Supplementary Fig. 7 ). Within these sequences, the areas corresponding to the loops 2-3, 4-5, 6-7 (i.e. β1-2 strand), 8-9 and 12-13 showed a high degree of variation ( Fig. 5a and Supplementary Fig. 7 ). As the binding site of ATC-1 and ATC-2 is located on these loops (6-7, 8-9
and 12-13 of chain A), it is unlikely that ATC would bind to the mPPases of pathogenic parasites as it does in the current TmPPase structure. To validate this, we built a homology model of P.
falciparum mPPase (PfPPase; Fig. 5b ). The loops 4-5, 6-7 and 12-13 of the modelled structure are notably shorter than those of TmPPase: the ATC binding site is not present, as loop 6-7 contributes about 2/3 of the interface (Table 2 ). This not only explains why ATC does not inhibit PfPPase, but also supports the notion it functions asymmetrically, preventing a full catalytic cycle from occurring by binding to one chain and preventing the exit channel from opening.
Discussion
The first novel inhibitors of integral membrane pyrophosphatases mPPases are potential targets for anti-protozoan drug design as they do not occur in humans and other mammals, are essential in P. falciparum (Totanes, unpubl.) and render T. gondii noninfectious 19 . Bisphosphonate derivatives (PP i analogues) can inhibit mung bean mPPase 24 and prevent the proliferation of T. gondii 25 and other protozoan parasites 26, 27 . However, they also inhibit human enzymes such as farnesyl pyrophosphate synthase, so they are not viable as anti-parasitic drug candidates (for a review, see 13 ). This study reports the first non-phosphorus inhibitors of mPPase, which were identified through a screening process. The best compound (ATC), binds and inhibits both the E 2 S and E 2 S 2 complexes, with inhibition constants K i2 and K i3 of 1.8 and 10.0 µM, respectively ( , but to our knowledge, this is the first one observed in mPPase.
Identification of alternate inhibitory mechanisms and evidence for allostery in mPPases
ATC clearly binds beside the exit channel ( Fig. 2 and Fig. 3 A recent study has shown that all mesophilic mPPases show substrate inhibition with increased K m and decreased V when two molecules of substrate are bound in the presence of 50 mM K + 22 . The binding of S to E 2 S is weaker than to E 2 , and k cat for E 2 S 2 is lower than for E 2 S. They interpreted this to mean that substrate binding to one monomer causes a conformational change in the other that inhibits its interaction with the substrate. Our ATC-bound structure ( Fig. 2 and Fig. 3 ) and inhibition data (Fig. 4 and , and Na + move up to 1.2 Å from their positions in the TmPPase:IDP structure (Fig. 1c) . This corresponds to a new state that, we believe, keeps the exit channel closed. Our current model 10 posits that, during ion pumping, TMH12 moves downward by at least 2 Å 9 .
Comparing the relative positions of the ATC-bound and resting states suggests that this movement of TMH12 makes loop12-13 move towards the dimeric interface of the protein and TMH13 move "up" towards the cytoplasmic side (Fig. 3d ). This would induce equal conformational changes in monomer B in the TmPPase:IDP. However, ATC binding locks monomer A TMH12 in the "down" state. Because of its "down" position, loop12-13 and TMH13 can still trigger the conformational changes of monomer B into a state that binds substrate more tightly. However, further catalysis is impossible because monomer B cannot undergo a full catalytic cycle: substrate can bind, but the full motions required for catalysis are impossible. Diagnostic of these motions is the conformation that leads to binding of ATC. In agreement with the structure, the kinetic data shows that ATC dimer only binds to one of the monomers, and binds most tightly to the TmPPase 2 (Mg 5 PP i ) state (Table 4 ).
The requirement for potassium for maximal activity and for substrate inhibition is also explained by these structures. The amino acid responsible for K + dependency (A495 12.46 in TmPPase) is located in TMH12, which is directly linked to the dimer interface (loop12-13 and TMH13). We suggest that, in the presence of K + , the downward movement of TMH12 upon substrate binding and ion pumping induces conformational changes in the monomer-monomer interface by the "away" movement of loop12-13 and upward movement of TMH13 (Fig. 4d) . This is then propagated to other TMHs. In the absence of K + , such coupling does not occur. These changes increase affinity and activity. They also provide a possible structural explanation for the Na 
Methods
Discovery of ATC and its analogues
The screening process that led to the discovery of compound 1 (ATC) will be described in more detail elsewhere. Briefly, we tested compounds using a recently developed 96-well plate assay with TmPPase as a model system 35 . The screening collections included compounds synthesized in our laboratories. The identification of ATC as an inhibitor was followed by the test of analogues 2-5.
ATC and its analogues were initially developed for their antimicrobial, antiviral and anticancer activities as reported elsewhere 36 .
Compound synthesis
The purity of all the compounds tested was above 95%. The synthesis of ATC (compound 1) and compounds 2-5 has been described elsewhere 36 . The synthesis of compounds 6-9 is described in supplemental material. For synthesis, all reactions were carried out using commercially available , 100 mM KCl, 10 mM NaCl) at 71 °C for 2 min.
Activity measurement and kinetic analysis
For analysis, we used a variant of Artukka, Luoto For the mechanism in scheme 1 with n=2 (i.e. only inhibitor dimers bind), the rate equation (1) 40 is:
where 
Crystallization, structure determination and analysis
For crystallization, the purified protein was buffer exchanged to the crystallization buffer (50 mM MES-NaOH pH 6.5, 3.5% (v/v) glycerol, 50 mM KCl, 5 mM MgCl 2 , 2 mM DTT and 0.5% OGNPG) on a Micro Bio-Spin 6 column (Bio-Rad) and then diluted to a concentration of 10 mg ml −1 . Prior to crystallization, 1 mM imidodiphosphate (IDP) and 1 mM ATC were added, the solution incubated on ice for 10 min, and centrifuged for 20 min (16,000 × g, 4 °C). Crystallization trials were done at 22 °C by sitting drop vapour-diffusion method using commercial screens, MemGold™ and PGA screen™ (Molecular Dimensions) in MRC 2-well crystallisation plates (Swissci) with a Mosquito robot (TPP Labtech) and the drops were monitored using the minstrel DT UV imaging system (Formulatrix). Crystal hits appeared in the MemGold™ screen under different conditions. Crystallization conditions were then optimised to get better crystals by varying pH, buffer, salt and PEG concentrations using the vapour-diffusion method in 1 μl + 1 μl (proteinmother liquor) drops in a 24-well plate at room temperature. Harvestable crystals appeared within a week and were frozen after soaking in cryo-protectant (mother liquor + 20% glycerol) or directly from mother liquor. The best diffracting crystal appeared from a solution containing 0.1 M MES pH 6.5, 0.1 M NaCl, 33% polyethylene glycol (PEG) 400, and 4% ethylene glycol.
X-ray diffraction data were collected at ESRF Grenoble (France) on the ID29 beamline at 100 K on a Pilatus 6M detector. 1400 images were collected at an oscillation angle of 0.1°. The data were merged and scaled using X-ray Detector Software (XDS) 41 and the structure solved by molecular replacement with Phaser 42 using the IDP-bound state of TmPPase structure (5LZQ) 10 as the search model. Phaser found a unique solution in space group P2 1 2 1 2 1 with four monomers in the asymmetric unit forming two dimers. The structure was built and refined using phenix.refine 43 and Coot 44 . The final model has R work /R free of 22.5%/26.8% with 94.1% of residues in the favoured and 5.7% in the allowed region of the Ramachandran plot ( Table 1 ).
The structural interface and assembly of the protein were analysed using the PDBe PISA server (http://www.ebi.ac.uk/pdbe/pisa/) 45 . Internal pocket analysis was done using the Splitpocket server (http://pocket.med.wayne.edu/patch/) 46, 47 . Structural alignments were done in PyMOL with the default setting using the monomer structure, except if stated differently. All structural figures were produced using PyMOL (https://pymol.org/2/).
Comparison with pathogenic mPPases
The sequences of TmPPase and 16 pathogenic mPPases were aligned using Clustal Omega software 48 , and conservation analysis was conducted and visualized with the ConSurf server 49, 50 with default parameters. The initial pairwise sequence alignment of TmPPase and P. falciparum mPPase (VP1; PfPPase; sequence identity 42%) was produced with Discovery Studio 4.5 software 51 using the Align123 algorithm. Homology modelling was carried out with MODELLER 9v14 52 with default settings in the Discovery Studio platform. The pairwise alignment was revised during the course of model building; in total nine models were constructed in three modelling rounds. The
Modeller DOPE scores did not differ significantly among these models, and a representative model was selected to minimize strain in the loops connecting transmembrane helices. 
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Figure Legends two joined red circles) to monomer A (wheat colour) (a) leads to Na + pumping (blue circle and blue arrow for the pumping direction) and induces a conformational change in monomer B (pink colour) (b) which increase its affinity for substrate binding. The Na + pumping causes the substrate hydrolysis (yellow lightning symbol for this event) in monomer A, while the substrate binding in monomer B leads to its Na + pumping (c). After hydrolysis, the monomer A released its hydrolysis products (2P i ; red circles) while monomer B proceed to the hydrolysis event (d) and then moves back to the state in a. The ATC dimer binds to its binding site after substrate binding and Na + pumping in monomer A (e) which lock this monomer in the "down" state. Even though no hydrolysis occurred in monomer A due to the ATC binding, its conformational change still able to induces a conformational change in monomer B that increase its substrate affinity (f). The numbering with white background corresponds to transmembrane helix number. 
